CAS number：1599440-13-7 molecular formula：C52H56FN9O13
Deruxtecan is an ADC drug-linker conjugate composed of an DX-8951 derivative (DXd) and amaleimide-GGFG peptide linker, used for synthesizing DS-8201 and U3-1402. In Vitro Antibody-drug conjugates deliver anticancer agents selectively and efficiently to tumor tissue and have significant antitumor efficacy with a wide therapeutic window. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:Camptothecins
| Chinese alias | 德鲁斯特康 | ||
| English alias | SCHEMBL17003548 | HY-13631E | MS-31882 | UNII-5SEB972CO4 | N-(6-(2,5-DIHYDRO-2,5-DIOXO-1H-PYRROL-1-YL)-1-OXOHEXYL)GLYCYLGLYCYL-L-PHENYLALANYL-N-((2-(((1S,9S)-9-ETHYL-5-FLUORO-2,3,9,10,13,15-HEXAHYDRO-9-HYDROXY-4-METHYL-10,13-DIOXO-1H,12H-BENZO(DE)PYRANO(3 | ||
| CAS number | 1599440-13-7 | molecular formula | C52H56FN9O13 |
| molecular weight | 1034.05 g/mol | Exact mass | ≥99% |
| PSA | 301.000 Ų | logp | -0.400 |
No numbering system information yet
No physical and chemical property information yet
No safety information yet
No production method and use information yet
No upstream information yet
No downstream information yet
